Could you take part in Alzheimer’s research?
We are looking for people aged 55 to 80 to take part in PrevenTRON, an international research study investigating whether a new drug could delay or prevent the onset of Alzheimer’s disease before symptoms begin.
You do not need to have Alzheimer’s disease or memory problems to take part.
Surrey and Borders Partnership NHS Foundation Trust is the lead recruitment site for the study in the UK and can recruit people from anywhere in the country.
What is the PrevenTRON study?
PrevenTRON is a phase III research study investigating a new drug called Trontinemab.
The study will look at whether Trontinemab can help delay or prevent Alzheimer’s disease in people who are at high risk of developing the disease, but who do not currently have symptoms or problems with their memory or thinking.
Around 1,600 people will take part at research sites around the world.
How does Trontinemab work?
Trontinemab works by removing amyloid plaques that build up in the brain and are associated with Alzheimer’s disease.
As part of the screening process, blood tests will be used to help identify people who are most likely to benefit from taking part in the trial.
Who can take part?
The study is recruiting healthy adults who:
- are aged 55 to 80
- do not have symptoms of Alzheimer’s disease
- do not have memory problems.
There will be a screening process to find out whether the study is suitable for you.
Interested in taking part?
If you would like to find out more about PrevenTRON and whether you may be able to take part, contact our Research and Development team.
Email: research@sabp.nhs.uk
Telephone: 01372 216584
You can contact us from anywhere in the UK.
PrevenTRON is sponsored by pharmaceutical company Roche.